HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients.

Abstract
Medroxyprogesterone acetate (MPA) and acetazolamide (ACET) are two ventilatory stimulants which are used in hypoxic and hypercapnic patients with chronic obstructive pulmonary disease (COPD). In a double-blind randomised study, the effects of a 2-week treatment with MPA (30 mg b.i.d.) or ACET (250 mg b.i.d.), followed by a 2-week treatment with a combination of both drugs (MPA/ACET), on daytime and nocturnal ventilatory and blood gas parameters in 17 stable hypercapnic COPD patients were investigated. ACET, MPA and MPA/ACET treatment decreased mean daytime carbon dioxide tension in arterial blood by 0.4, 0.7 and 1.2 kPa, respectively. Minute ventilation was improved only with combined therapy, from 9.3 to 11.2 L x min(-1). With MPA/ACET therapy, the hypercapnic and hypoxic ventilatory responses significantly increased, from 3.7 to 5.8 L x min(-1) x kPa(-1) and from -0.13 to -0.40 L x min(-1) x %(-1), respectively. The mouth exclusion pressure response to hypoxia increased during combination therapy, from -0.01 to -0.03 kPa %(-1). Nocturnal end-tidal carbon dioxide tension decreased with MPA and MPA/ACET treatment, by 0.9 and 1.4 kPa, respectively. MPA/ACET significantly increased mean nocturnal arterial oxygen saturation values, from 85.5 to 90.2%. The authors conclude that short-term combined treatment with medroxyprogesterone acetate and acetazolamide has a more favourable effect on day and night-time blood gas values and chemical drive than single drug treatment.
AuthorsM Wagenaar, P Je Vos, Y F Heijdra, L J Teppema, H T M Folgering
JournalThe European respiratory journal (Eur Respir J) Vol. 20 Issue 5 Pg. 1130-7 (Nov 2002) ISSN: 0903-1936 [Print] England
PMID12449165 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbonic Anhydrase Inhibitors
  • Carbon Dioxide
  • Medroxyprogesterone
  • Acetazolamide
  • Oxygen
Topics
  • Acetazolamide (administration & dosage)
  • Aged
  • Carbon Dioxide (blood)
  • Carbonic Anhydrase Inhibitors (administration & dosage)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Humans
  • Hypercapnia (complications, drug therapy, physiopathology)
  • Hypoxia (complications, drug therapy, physiopathology)
  • Medroxyprogesterone (administration & dosage)
  • Oxygen (blood)
  • Pulmonary Disease, Chronic Obstructive (complications, drug therapy, physiopathology)
  • Respiration (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: